European Archives of Oto-Rhino-Laryngology

, Volume 276, Issue 7, pp 2113–2114 | Cite as

In reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De-ESCALaTE

  • Petar SutonEmail author
  • Marko Skelin
  • Zoran Rakusic
  • Stjepan Dokuzovic
  • Ivica Luksic
Letter to the Editor


Compliance with ethical standards

Conflict of interest

We disclose any commercial associations that might pose a potential, perceived or real conflict of interest with the content of this article. These include grants, patent licensing arrangements, consultancies, stock or other equity ownership, donations, advisory board memberships, or payments for conducting or publicizing the study.


  1. 1.
    Swain M, Gupta T, Kannan S, Agarwal J (2019) Cisplatin-based chemoradiotherapy trumps cetuximab-based bioradiotherapy in p16/HPV-positive oropharyngeal cancers. Eur Arch Otorhinolaryngol. CrossRefPubMedGoogle Scholar
  2. 2.
    Suton P, Skelin M, Rakusic Z, Dokuzovic S, Luksic I (2019) Cisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE. Eur Arch Oto-Rhino-Laryngol 276:1275–1281. CrossRefGoogle Scholar
  3. 3.
    Riaz N, Baschnagel A, Adkins D, Rao S, Huang J, Chen P et al (2014) Multi-institution analysis of concurrent chemoradiation therapy with cisplatin (CDDP) versus cetuximab (C225) in locally advanced squamous cell carcinoma of the head and neck (LAHNSCC): can HPV help decide which agent? Int J Radiat Oncol Biol Phys 88:472CrossRefGoogle Scholar
  4. 4.
    Suton P, Skelin M, Luksic I (2018) Concurrent cisplatin-based chemoradiotherapy versus cetuximab-based bioradiotherapy for p16-positive, locally advanced oropharyngeal cancer: a meta-analysis. Ann Oncol 29(suppl_8):viii372–viii399. CrossRefGoogle Scholar
  5. 5.
    Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567–578CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Radiotherapy and Medical OncologyUniversity Hospital Centre “Sisters of Mercy”, University Hospital for TumorsZagrebCroatia
  2. 2.Pharmacy DepartmentGeneral Hospital SibenikSibenikCroatia
  3. 3.Department of OncologyUniversity Hospital Centre ZagrebZagrebCroatia
  4. 4.Department of Traumatology and OrthopaedicsUniversity Hospital DubravaZagrebCroatia
  5. 5.Department of Maxillofacial SurgeryUniversity Hospital Dubrava, University of Zagreb School of MedicineZagrebCroatia

Personalised recommendations